BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|January 1, 2007
- Volume 0 0
A CAREER PLANNING FLOWCHART FOR THE PHARMACY STUDENT
Author(s)Tom O'Connor, PharmD, MBA
Advertisement
Articles in this issue
almost 20 years ago
COMMUNITY PHARMACY STILL GOING STRONGalmost 20 years ago
Seven Deadly Sins and How to Avoid Them: Résumésalmost 20 years ago
Seven Deadly Sins and How to Avoid Them: Interviewsalmost 20 years ago
DOCTOR TOM'S TOP TEN TIPS: PASSING THE PHARMACY BOARDSalmost 20 years ago
KAISER PERMANENTE ENCOURAGES PHARMACISTS TO STRIVEalmost 20 years ago
PUBLIX PHARMACISTS BUILD LASTING RELATIONSHIPSalmost 20 years ago
A JUGGLING ACT: MULTI-TASKING IN CLINICAL TRIALS OPERATIONSalmost 20 years ago
A WALGREENS CAREER: VARIETY CHALLENGES PHARMACISTSalmost 20 years ago
CVS SEEKS REMARKABLE PHARMACISTS FOR REMARKABLE CAREERSalmost 20 years ago
RITE AID PHARMACISTS REACH OUT TO UNDERSERVED POPULATIONSAdvertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What the 2025-2030 Dietary Guidelines Mean for Heart Health
2
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
5